Trials / Unknown
UnknownNCT02294305
Vortioxetine Versus Placebo in Major Depressive Disorder Comorbid With Social Anxiety Disorder
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- The Medical Research Network · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This placebo-controlled study is designed to determine the efficacy, safety, and tolerability of vortioxetine in the treatment of adults with Major Depressive Disorder (MDD) that is comorbid with Social Anxiety Disorder (SAD). Half of the subjects will be randomized to receive vortioxetine and the other half will receive placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vortioxetine | |
| DRUG | Placebo |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2016-11-01
- Completion
- 2016-11-01
- First posted
- 2014-11-19
- Last updated
- 2016-08-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02294305. Inclusion in this directory is not an endorsement.